Hypofractionated, Reduced Margin, Intensity Modulated Radiotherapy with Concurrent and Adjuvant Temozolomide for Patients with Glioblastoma Multiforme: A Pattern of Failure Analysis

被引：0
|
作者：
Shakibnia, L. [1 ]
Roberge, D. [1 ]
Souhami, L. [1 ]
Lambert, C. [1 ]
Raymond, V. Panet [1 ]
Shenouda, G. [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S280 / S280
页数：1
相关论文
共 50 条
  • [31] The efficacy of hypofractionated radiotherapy (HFRT) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: A meta-analysis
    Guo, Longbin
    Li, Xuanzi
    Chen, Yulei
    Liu, Rongping
    Ren, Chen
    Du, Shasha
    CANCER RADIOTHERAPIE, 2021, 25 (02): : 182 - 190
  • [32] Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma
    Minniti, Giuseppe
    De Sanctis, V.
    Muni, R.
    Rasio, D.
    Lanzetta, G.
    Bozzao, A.
    Osti, M. F.
    Salvati, M.
    Valeriani, M.
    Cantore, G. P.
    Enrici, R. Maurizi
    JOURNAL OF NEURO-ONCOLOGY, 2009, 91 (01) : 95 - 100
  • [33] Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma
    Giuseppe Minniti
    V. De Sanctis
    R. Muni
    D. Rasio
    G. Lanzetta
    A. Bozzao
    M. F. Osti
    M. Salvati
    M. Valeriani
    G. P. Cantore
    R. Maurizi Enrici
    Journal of Neuro-Oncology, 2009, 91 : 95 - 100
  • [34] Hypofractionated intensity-modulated radiation therapy and temozolomide for patients with glioblastoma
    Souhami, Luis
    Roberge, David
    Kavan, Petr
    Muanza, Thierry
    Lambert, Christine
    Guiot, Marie Christine
    Del Maestro, Rolando
    Leblanc, Richard
    Shenouda, George
    NEURO-ONCOLOGY, 2007, 9 (04) : 583 - 583
  • [35] Phase II Trial of Hypofractionated Intensity Modulated Radiotherapy to 60 Gy in 10 Fractions with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma Multiforme
    Reddy, K.
    Damek, D.
    Gaspar, L.
    Ney, D.
    Kavanagh, B.
    Waziri, A.
    Lillehei, K.
    Stuhr, K.
    Chen, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S130 - S130
  • [36] RADIOTHERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE IN GLIOBLASTOMA MULTIFORME PATIENTS: A PROSPECTIVE STUDY
    Sarihan, S.
    Yildirim, S.
    Ozturk, H.
    Evrensel, T.
    Kocaeli, H.
    Tolunay, S.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S216 - S216
  • [37] Concurrent Bevacizumab and Temozolomide Alters the Pattern of Failure in Radiation Treatment of Glioblastoma Multiforme
    Spalding, A. C.
    Wagner, S. A.
    Vitaz, T. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S10 - S10
  • [38] Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
    Gebhardt, Brian J.
    Dobelbower, Michael C.
    Ennis, William H.
    Bag, Asim K.
    Markert, James M.
    Fiveash, John B.
    RADIATION ONCOLOGY, 2014, 9
  • [39] Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide
    Brian J Gebhardt
    Michael C Dobelbower
    William H Ennis
    Asim K Bag
    James M Markert
    John B Fiveash
    Radiation Oncology, 9
  • [40] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Alonso-Basanta, Michelle
    Fang, Penny
    Maity, Amit
    Hahn, Stephen M.
    Lustig, Robert A.
    Dorsey, Jay F.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (02) : 365 - 372
12345